In this study, we newly designed a water-soluble zwitterionic heptamethine cyanine dye, named CA800-PR, to enable tumor-specific uptake, targeted NIR fluorescence imaging, and enhanced therapeutic efficacy in the HR+ breast cancer. This evidence concerns the gene PGR and breast cancer.